Fed. Circ. Ruling Clears Way For Longer Patent Terms

Law360, New York (January 15, 2014, 7:46 PM EST) -- The Federal Circuit ruled Wednesday that the U.S. Patent and Trademark Office had incorrectly calculated patent term adjustments, a win for Novartis AG that attorneys say opens the door for many companies to extend the lives of their patents.

The appeals court agreed with Novartis that in cases where a patent applicant files a request for continued examination, the patent office has calculated patent term adjustments — the time added to the life of patents to compensate for delays in examination — in a way that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.